基于蛋白质的组织粘合剂缩短了外周血管手术的止血时间。

IF 0.9 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE
Vascular Pub Date : 2025-06-01 Epub Date: 2024-05-30 DOI:10.1177/17085381241258556
Nicola Troisi, Michele Marconi, Stefano Michelagnoli, Patrizia Dalla Caneva, Pierfrancesco Frosini, Rossella Di Domenico, Carlo Pratesi, Raffaella Berchiolli
{"title":"基于蛋白质的组织粘合剂缩短了外周血管手术的止血时间。","authors":"Nicola Troisi, Michele Marconi, Stefano Michelagnoli, Patrizia Dalla Caneva, Pierfrancesco Frosini, Rossella Di Domenico, Carlo Pratesi, Raffaella Berchiolli","doi":"10.1177/17085381241258556","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectivesThe aim of this study was to evaluate the effectiveness of protein-based tissue adhesive (Bioglue<sup>®</sup>) in reducing time to haemostasis in patients undergoing peripheral vascular surgery.MethodsFrom January to December 2021, 100 consecutive patients from 4 centres have been treated with open peripheral vascular surgery including upper and lower limb interventions. Patients have been allocated in each centre into control with no use of Bioglue<sup>®</sup> (<i>Group no-Bio</i>, 50 patients) or use of Bioglue<sup>®</sup> (<i>Group Bio</i>, 50 patients) by a block randomization method 10:10 until the required sample size was reached. Perioperative parameters including time to haemostasis, number of adjunctive stitches, and in-hospital bleeding have been analysed and compared in the two groups by means of mean independent-samples <i>t</i>T -test and Gehan-Breslow-Wilcoxon test.ResultsBoth groups were homogeneous in terms of demographic data, preoperative risk factors, and preoperative medical therapy except for a higher percentage of active smokers in <i>Group Bio</i> (52% vs. 24%, <i>p</i> = 0.004). Femoral endarterectomy was most common in <i>Group Bio</i> (44% vs. 24%, <i>p</i> = 0.03), whilst the percentage of lower limb vein bypasses was higher in <i>Group no-Bio</i> (50% vs. 36%, <i>p</i> = 0.03). Bovine pericardium was the preferred material in <i>Group Bio</i> (20 cases, 40%), whilst autologous vein is mostly used in <i>Group no-Bio</i> (26 cases, 52%) (<i>p</i> = 0.01). Time to haemostasis was faster in <i>Group Bio</i> (4.4 vs. 9.6 minutes, <i>p</i> < 0.001). The need for adjunctive stitches was higher in <i>Group no-Bio</i> (8 cases, 16%, <i>Group Bio</i> vs. 25 cases, 50%, <i>Group no-Bio</i>; <i>p</i> < 0.001). The overall rate of in-hospital bleeding, including those requiring reintervention, was not different between the two groups (9 cases, 18%, <i>Group Bio</i> vs. 7 cases, 14%, <i>Group no-Bio</i>; <i>p</i> = 0.39).ConclusionsThe protein-based tissue adhesive Bioglue<sup>®</sup> reduced time to haemostasis and need for adjunctive stitches in peripheral vascular surgery. However, it did not affect the overall rate of perioperative bleedings. Further studies with larger sample sizes are needed to validate these outcomes.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"710-716"},"PeriodicalIF":0.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Protein-based tissue adhesive reduces time to haemostasis in peripheral vascular surgery.\",\"authors\":\"Nicola Troisi, Michele Marconi, Stefano Michelagnoli, Patrizia Dalla Caneva, Pierfrancesco Frosini, Rossella Di Domenico, Carlo Pratesi, Raffaella Berchiolli\",\"doi\":\"10.1177/17085381241258556\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ObjectivesThe aim of this study was to evaluate the effectiveness of protein-based tissue adhesive (Bioglue<sup>®</sup>) in reducing time to haemostasis in patients undergoing peripheral vascular surgery.MethodsFrom January to December 2021, 100 consecutive patients from 4 centres have been treated with open peripheral vascular surgery including upper and lower limb interventions. Patients have been allocated in each centre into control with no use of Bioglue<sup>®</sup> (<i>Group no-Bio</i>, 50 patients) or use of Bioglue<sup>®</sup> (<i>Group Bio</i>, 50 patients) by a block randomization method 10:10 until the required sample size was reached. Perioperative parameters including time to haemostasis, number of adjunctive stitches, and in-hospital bleeding have been analysed and compared in the two groups by means of mean independent-samples <i>t</i>T -test and Gehan-Breslow-Wilcoxon test.ResultsBoth groups were homogeneous in terms of demographic data, preoperative risk factors, and preoperative medical therapy except for a higher percentage of active smokers in <i>Group Bio</i> (52% vs. 24%, <i>p</i> = 0.004). Femoral endarterectomy was most common in <i>Group Bio</i> (44% vs. 24%, <i>p</i> = 0.03), whilst the percentage of lower limb vein bypasses was higher in <i>Group no-Bio</i> (50% vs. 36%, <i>p</i> = 0.03). Bovine pericardium was the preferred material in <i>Group Bio</i> (20 cases, 40%), whilst autologous vein is mostly used in <i>Group no-Bio</i> (26 cases, 52%) (<i>p</i> = 0.01). Time to haemostasis was faster in <i>Group Bio</i> (4.4 vs. 9.6 minutes, <i>p</i> < 0.001). The need for adjunctive stitches was higher in <i>Group no-Bio</i> (8 cases, 16%, <i>Group Bio</i> vs. 25 cases, 50%, <i>Group no-Bio</i>; <i>p</i> < 0.001). The overall rate of in-hospital bleeding, including those requiring reintervention, was not different between the two groups (9 cases, 18%, <i>Group Bio</i> vs. 7 cases, 14%, <i>Group no-Bio</i>; <i>p</i> = 0.39).ConclusionsThe protein-based tissue adhesive Bioglue<sup>®</sup> reduced time to haemostasis and need for adjunctive stitches in peripheral vascular surgery. However, it did not affect the overall rate of perioperative bleedings. Further studies with larger sample sizes are needed to validate these outcomes.</p>\",\"PeriodicalId\":23549,\"journal\":{\"name\":\"Vascular\",\"volume\":\" \",\"pages\":\"710-716\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17085381241258556\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17085381241258556","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

研究目的本研究旨在评估蛋白基组织粘合剂(Bioglue®)在缩短外周血管手术患者止血时间方面的效果:从 2021 年 1 月到 12 月,来自 4 个中心的 100 名连续患者接受了开放性外周血管手术治疗,包括上肢和下肢介入治疗。每个中心通过10:10的分块随机法将患者分配到不使用百优解®的对照组(无百优解组,50名患者)或使用百优解®的对照组(百优解组,50名患者),直到达到所需的样本量。通过平均独立样本 tT 检验和 Gehan-Breslow-Wilcoxon 检验,分析并比较了两组患者的围手术期参数,包括止血时间、辅助缝合次数和院内出血量:两组患者在人口统计学数据、术前风险因素和术前药物治疗方面均无差异,但 Bio 组的活跃吸烟者比例较高(52% 对 24%,P = 0.004)。股骨内膜切除术在生化组最为常见(44% 对 24%,P = 0.03),而下肢静脉搭桥术在无生化组中比例更高(50% 对 36%,P = 0.03)。生化组首选材料是牛心包(20 例,40%),而非生化组主要使用自体静脉(26 例,52%)(p = 0.01)。生物组的止血时间更快(4.4 分钟对 9.6 分钟,p < 0.001)。无生物组需要辅助缝合的比例更高(生物组 8 例,16%;无生物组 25 例,50%;p < 0.001)。两组的院内出血总发生率,包括需要再次手术的出血总发生率没有差异(生物组 9 例,18%;无生物组 7 例,14%;P = 0.39):结论:基于蛋白质的组织粘合剂 Bioglue® 缩短了外周血管手术的止血时间,减少了辅助缝合的需要。结论:蛋白基组织粘合剂 Bioglue® 减少了外周血管手术的止血时间和辅助缝合的需要,但并未影响围术期出血的总发生率。要验证这些结果,还需要进行样本量更大的进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Protein-based tissue adhesive reduces time to haemostasis in peripheral vascular surgery.

ObjectivesThe aim of this study was to evaluate the effectiveness of protein-based tissue adhesive (Bioglue®) in reducing time to haemostasis in patients undergoing peripheral vascular surgery.MethodsFrom January to December 2021, 100 consecutive patients from 4 centres have been treated with open peripheral vascular surgery including upper and lower limb interventions. Patients have been allocated in each centre into control with no use of Bioglue® (Group no-Bio, 50 patients) or use of Bioglue® (Group Bio, 50 patients) by a block randomization method 10:10 until the required sample size was reached. Perioperative parameters including time to haemostasis, number of adjunctive stitches, and in-hospital bleeding have been analysed and compared in the two groups by means of mean independent-samples tT -test and Gehan-Breslow-Wilcoxon test.ResultsBoth groups were homogeneous in terms of demographic data, preoperative risk factors, and preoperative medical therapy except for a higher percentage of active smokers in Group Bio (52% vs. 24%, p = 0.004). Femoral endarterectomy was most common in Group Bio (44% vs. 24%, p = 0.03), whilst the percentage of lower limb vein bypasses was higher in Group no-Bio (50% vs. 36%, p = 0.03). Bovine pericardium was the preferred material in Group Bio (20 cases, 40%), whilst autologous vein is mostly used in Group no-Bio (26 cases, 52%) (p = 0.01). Time to haemostasis was faster in Group Bio (4.4 vs. 9.6 minutes, p < 0.001). The need for adjunctive stitches was higher in Group no-Bio (8 cases, 16%, Group Bio vs. 25 cases, 50%, Group no-Bio; p < 0.001). The overall rate of in-hospital bleeding, including those requiring reintervention, was not different between the two groups (9 cases, 18%, Group Bio vs. 7 cases, 14%, Group no-Bio; p = 0.39).ConclusionsThe protein-based tissue adhesive Bioglue® reduced time to haemostasis and need for adjunctive stitches in peripheral vascular surgery. However, it did not affect the overall rate of perioperative bleedings. Further studies with larger sample sizes are needed to validate these outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vascular
Vascular 医学-外周血管病
CiteScore
2.30
自引率
9.10%
发文量
196
审稿时长
6-12 weeks
期刊介绍: Vascular provides readers with new and unusual up-to-date articles and case reports focusing on vascular and endovascular topics. It is a highly international forum for the discussion and debate of all aspects of this distinct surgical specialty. It also features opinion pieces, literature reviews and controversial issues presented from various points of view.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信